1 min read

Updated CDLT Data Reporting Period to Begin May 1

Updated CDLT Data Reporting Period to Begin May 1

Effective May 1, clinical diagnostic laboratories will be required to follow new data reporting requirements for clinical diagnostic laboratory tests that are not advanced diagnostic laboratory tests.

All independent, physician office, and hospital outreach laboratories that meet the definition of “applicable laboratory” under the Clinical Laboratory Fee Schedule (CLFS) will be subject to a data reporting period from May 1 to July 31, 2026, for the updated data collection period of Jan. 1 to June 30, 2025. This data collection period was updated according to language in Section 6226 of the Continuing Appropriations Act (CAA) of 2026, which was passed on Feb. 3, 2026.

The following data must be reported:

  • Applicable HCPCS codes
  • Associated private payer rates
  • Volume data

Another provision of the CAA delayed the phase-in of payment reductions under the CLFS from private payer rate implementation. Starting Jan. 1, 2027 to 2029, payment may not be reduced by more than 15 percent per year compared with the amount established for a test during the preceding year.

Sources:

https://www.cms.gov/training-education/medicare-learning-network/newsletter/mln-connects-newsletter-march-12-2026#_Toc224192914

https://www.cms.gov/medicare/payment/fee-schedules/clinical-laboratory-fee-schedule-clfs

Updated CDLT Data Reporting Period to Begin May 1

Updated CDLT Data Reporting Period to Begin May 1

Effective May 1, clinical diagnostic laboratories will be required to follow new data reporting requirements for clinical diagnostic laboratory tests...

Read More
TELCOR Promotions - March 2025

TELCOR Promotions - March 2025

Lincoln, NE – March 2026 TELCOR is proud to announce the promotion of Carl Dillow to Senior Analyst, RCM, Erik Spitz to Senior Analyst, RCM, and Dani...

Read More
Trump Administration Imposes Temporary Import Duties Following Supreme Court Ruling

Trump Administration Imposes Temporary Import Duties Following Supreme Court Ruling

Despite recent legal challenges to the Trump administration’s sweeping tariffs, a Section 232 investigation is ongoing for imports of medical...

Read More